Open-mkt buys · 90d
$11.85M
34 trades · 3 insiders
Open-mkt sales · 90d
$558.0K
10 trades · 1 insiders
Net · 90d
$11.29M
Insiders on file
15
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Lappe Mark | Chief Executive Officer, Director | 63 | $10.55M | $2.82M | 2026-10-14 |
| Kayyem Jon Faiz | Director | 51 | $10.58M | $1.07M | 2026-09-23 |
| MANHARD KIMBERLY | Director | 24 | $139.8K | $558.0K | 2026-09-15 |
| FORSYTH DOUGLAS | Director | 18 | $1.61M | $0 | 2026-09-08 |
| Vuori Kristiina MD | Director | 14 | $300.0K | $0 | 2026-06-03 |
| Matly David | President | 2 | $0 | $0 | 2026-04-24 |
| Viking Global Opportunities Parent GP LLC | 10% Owner | 3 | $0 | $11.29M | 2025-10-07 |
| Deck Kelly | Chief Financial Officer | 21 | $0 | $0 | 2025-04-01 |
| Eckelman Brendan P. | Chief Scientific Officer | 54 | $0 | $19.52M | 2024-05-30 |
| VIKING GLOBAL INVESTORS LP | 10% Owner | 7 | $2.55M | $0 | 2024-05-30 |
| Inhibrx, Inc. | 10% Owner | 1 | $0 | $0 | 2024-05-29 |
| Ott David C. | 10% Owner | 4 | $70.00M | $0 | 2023-08-28 |
| Wagner Klaus W. | Chief Medical Officer | 3 | $0 | $4.30M | 2021-02-17 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 10% Owner | 2 | $3.41M | $0 | 2020-08-26 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | 2 | $0 | $0 | 2020-08-21 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-10-14 | 2026-10-14 | 100 | $85.76 | $8.6K | 170,000 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-10-14 | 2026-10-14 | 2,451 | $85.00 | $208.3K | 169,900 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-10-14 | 2026-10-14 | 2,449 | $84.07 | $205.9K | 167,449 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-10-14 | 2026-10-14 | 100 | $85.76 | $8.6K | 745,588 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-10-14 | 2026-10-14 | 2,470 | $85.00 | $209.9K | 745,488 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-10-14 | 2026-10-14 | 2,470 | $84.07 | $207.7K | 743,018 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2026-09-28 | 2026-09-28 | 3,000 | $101.70 | $305.1K | 740,548 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2026-09-28 | 2026-09-28 | 1,500 | $98.88 | $148.3K | 737,548 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-09-28 | 2026-09-28 | 3,000 | $101.70 | $305.1K | 740,548 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-09-28 | 2026-09-28 | 1,500 | $98.88 | $148.3K | 737,548 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2026-09-25 | 2026-09-28 | 2,176 | $99.60 | $216.7K | 736,048 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2026-09-25 | 2026-09-28 | 3,324 | $98.87 | $328.6K | 733,872 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-09-25 | 2026-09-28 | 2,176 | $99.60 | $216.7K | 736,048 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-09-25 | 2026-09-28 | 3,324 | $98.87 | $328.6K | 733,872 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2026-09-23 | 2026-09-23 | 5,000 | $100.00 | $500.0K | 434,360 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2026-09-23 | 2026-09-23 | 5,000 | $100.00 | $500.0K | 434,360 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2026-09-16 | 2026-09-17 | 5,000 | $100.00 | $500.0K | 429,360 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2026-09-16 | 2026-09-17 | 5,000 | $100.00 | $500.0K | 429,360 | SEC↗ |
| MANHARD KIMBERLY | Director | S Sale | 2026-09-15 | 2026-09-15 | 500 | $105.05 | $52.5K | 7,500 | SEC↗ |
| MANHARD KIMBERLY | Director | S Sale | 2026-09-15 | 2026-09-15 | 500 | $105.05 | $52.5K | 7,500 | SEC↗ |
| MANHARD KIMBERLY | Director | S Sale | 2026-09-14 | 2026-09-15 | 500 | $110.26 | $55.1K | 8,000 | SEC↗ |
| MANHARD KIMBERLY | Director | S Sale | 2026-09-14 | 2026-09-15 | 500 | $110.26 | $55.1K | 8,000 | SEC↗ |
| MANHARD KIMBERLY | Director | S Sale | 2026-09-11 | 2026-09-15 | 500 | $111.78 | $55.9K | 8,500 | SEC↗ |
| MANHARD KIMBERLY | Director | S Sale | 2026-09-11 | 2026-09-15 | 500 | $111.78 | $55.9K | 8,500 | SEC↗ |
| MANHARD KIMBERLY | Director | S Sale | 2026-09-09 | 2026-09-10 | 500 | $115.80 | $57.9K | 9,000 | SEC↗ |
| MANHARD KIMBERLY | Director | S Sale | 2026-09-09 | 2026-09-10 | 500 | $115.80 | $57.9K | 9,000 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2026-09-08 | 2026-09-08 | 1,100 | $107.12 | $117.8K | 719,148 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2026-09-08 | 2026-09-08 | 6,605 | $100.64 | $664.7K | 718,048 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2026-09-08 | 2026-09-08 | 5,895 | $99.29 | $585.3K | 711,443 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2026-09-08 | 2026-09-08 | 1,219 | $111.88 | $136.4K | 720,867 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2026-09-08 | 2026-09-08 | 9,681 | $112.28 | $1.09M | 730,548 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2026-09-08 | 2026-09-08 | 500 | $108.24 | $54.1K | 719,648 | SEC↗ |
| FORSYTH DOUGLAS | Director | P Buy | 2026-09-08 | 2026-09-08 | 2,500 | $114.65 | $286.6K | 227,064 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2026-09-08 | 2026-09-08 | 5,000 | $113.52 | $567.6K | 424,360 | SEC↗ |
| MANHARD KIMBERLY | Director | S Sale | 2026-09-08 | 2026-09-10 | 500 | $115.14 | $57.6K | 9,500 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2026-09-08 | 2026-09-08 | 5,000 | $113.52 | $567.6K | 424,360 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-09-08 | 2026-09-08 | 9,681 | $112.28 | $1.09M | 730,548 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-09-08 | 2026-09-08 | 1,219 | $111.88 | $136.4K | 720,867 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-09-08 | 2026-09-08 | 500 | $108.23 | $54.1K | 719,648 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-09-08 | 2026-09-08 | 1,100 | $107.12 | $117.8K | 719,148 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-09-08 | 2026-09-08 | 6,605 | $100.64 | $664.7K | 718,048 | SEC↗ |
| Lappe Mark | Chief Executive Officer, Dir | P Buy | 2026-09-08 | 2026-09-08 | 5,895 | $99.29 | $585.3K | 711,443 | SEC↗ |
| FORSYTH DOUGLAS | Director | P Buy | 2026-09-08 | 2026-09-08 | 2,500 | $114.65 | $286.6K | 227,064 | SEC↗ |
| MANHARD KIMBERLY | Director | S Sale | 2026-09-08 | 2026-09-10 | 500 | $115.14 | $57.6K | 9,500 | SEC↗ |
| Kayyem Jon Faiz | Director | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MANHARD KIMBERLY | Director | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Vuori Kristiina MD | Director | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FORSYTH DOUGLAS | Director | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MANHARD KIMBERLY | Director | A Award deriv | 2026-06-03 | 2026-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FORSYTH DOUGLAS | Director | A Award deriv | 2026-06-03 | 2026-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kayyem Jon Faiz | Director | A Award deriv | 2026-06-03 | 2026-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Vuori Kristiina MD | Director | A Award deriv | 2026-06-03 | 2026-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Vuori Kristiina MD | Director | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Kayyem Jon Faiz | Director | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MANHARD KIMBERLY | Director | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FORSYTH DOUGLAS | Director | A Award deriv | 2026-06-03 | 2026-09-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Matly David | President | A Award deriv | 2026-04-24 | 2026-04-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Viking Global Opportunities Pa | 10% Owner | S Sale | 2025-10-07 | 2025-10-09 | 25,042 | $32.25 | $807.6K | 102,864 | SEC↗ |
| Viking Global Opportunities Pa | 10% Owner | S Sale | 2025-10-07 | 2025-10-09 | 308,643 | $32.25 | $9.95M | 1,267,823 | SEC↗ |
| Viking Global Opportunities Pa | 10% Owner | S Sale | 2025-10-07 | 2025-10-09 | 16,315 | $32.25 | $526.2K | 67,018 | SEC↗ |
| FORSYTH DOUGLAS | Director | A Award deriv | 2025-05-28 | 2025-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kayyem Jon Faiz | Director | A Award deriv | 2025-05-28 | 2025-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Vuori Kristiina MD | Director | A Award deriv | 2025-05-28 | 2025-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MANHARD KIMBERLY | Director | A Award deriv | 2025-05-28 | 2025-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Matly David | President | A Award deriv | 2025-04-01 | 2025-04-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Deck Kelly | Chief Financial Officer | A Award deriv | 2025-04-01 | 2025-04-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2025-03-27 | 2025-03-28 | 90,000 | — | $0 | 419,360 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2024-12-16 | 2024-12-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2024-12-16 | 2024-12-17 | 500,000 | — | $0 | 509,360 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2024-12-16 | 2024-12-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2024-12-06 | 2024-12-06 | 52,000 | — | $0 | 1,009,360 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-11-20 | 2024-11-22 | 18,750 | $14.19 | $266.1K | 69,843 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-11-20 | 2024-11-22 | 18,750 | $14.19 | $266.1K | 69,843 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-11-19 | 2024-11-22 | 34,843 | $14.23 | $495.8K | 51,093 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-11-19 | 2024-11-22 | 34,843 | $14.23 | $495.8K | 51,093 | SEC↗ |
| Vuori Kristiina MD | Director | P Buy | 2024-10-03 | 2024-10-07 | 6,667 | $15.00 | $100.0K | 20,443 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-09-16 | 2024-09-16 | 13,037 | $17.13 | $223.3K | 705,548 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-09-12 | 2024-09-16 | 26,963 | $15.05 | $405.8K | 692,511 | SEC↗ |
| Vuori Kristiina MD | Director | P Buy | 2024-09-11 | 2024-09-12 | 6,457 | $15.07 | $97.3K | 13,776 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-09-10 | 2024-09-10 | 8,500 | $15.19 | $129.1K | 665,548 | SEC↗ |
| Vuori Kristiina MD | Director | P Buy | 2024-09-10 | 2024-09-12 | 179 | $15.00 | $2.7K | 7,319 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-09-09 | 2024-09-10 | 9,500 | $15.21 | $144.5K | 657,048 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-09-06 | 2024-09-10 | 26,000 | $15.29 | $397.5K | 647,548 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-09-03 | 2024-09-03 | 15,288 | $15.66 | $239.4K | 160,288 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-09-03 | 2024-09-03 | 4,712 | $16.31 | $76.9K | 165,000 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-08-30 | 2024-09-03 | 10,000 | $14.02 | $140.2K | 145,000 | SEC↗ |
| Vuori Kristiina MD | Director | P Buy | 2024-08-29 | 2024-09-03 | 7,140 | $14.00 | $100.0K | 7,140 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-08-29 | 2024-09-03 | 10,000 | $14.03 | $140.3K | 135,000 | SEC↗ |
| MANHARD KIMBERLY | Director | P Buy | 2024-08-28 | 2024-08-30 | 10,000 | $13.98 | $139.8K | 10,000 | SEC↗ |
| FORSYTH DOUGLAS | Director | P Buy | 2024-08-23 | 2024-08-26 | 59,812 | $14.07 | $841.6K | 224,564 | SEC↗ |
| FORSYTH DOUGLAS | Director | P Buy | 2024-08-22 | 2024-08-26 | 15,188 | $12.89 | $195.8K | 164,752 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-08-21 | 2024-08-22 | 12,945 | $12.93 | $167.4K | 54,865 | SEC↗ |
| Lappe Mark | Chief Executive Officer | P Buy | 2024-08-20 | 2024-08-22 | 27,055 | $12.97 | $350.9K | 41,920 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2024-06-24 | 2024-06-24 | 10,000 | — | $0 | 16,250 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2024-06-24 | 2024-06-24 | 89,050 | — | $0 | 1,061,360 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2024-06-24 | 2024-06-24 | 10,000 | — | $0 | 16,250 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-06-05 | 2024-06-07 | 49,284 | $17.23 | $849.2K | 1,142,145 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-06-05 | 2024-06-07 | 8,265 | $17.89 | $147.9K | 1,150,410 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-06-04 | 2024-06-04 | 23,726 | $18.24 | $432.8K | 1,092,861 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-06-04 | 2024-06-04 | 65,337 | $17.44 | $1.14M | 1,069,135 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-06-03 | 2024-06-04 | 46,792 | $16.61 | $777.2K | 923,060 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-06-03 | 2024-06-04 | 80,738 | $17.90 | $1.45M | 1,003,798 | SEC↗ |
| Kayyem Jon Faiz | Director | P Buy | 2024-05-31 | 2024-06-04 | 70,193 | $16.14 | $1.13M | 876,268 | SEC↗ |
| Deck Kelly | Chief Financial Officer | D To issuer deriv | 2024-05-30 | 2024-05-30 | 21,250 | — | $0 | 0 | SEC↗ |
| Deck Kelly | Chief Financial Officer | D To issuer deriv | 2024-05-30 | 2024-05-30 | 9,167 | — | $0 | 0 | SEC↗ |
| Deck Kelly | Chief Financial Officer | D To issuer deriv | 2024-05-30 | 2024-05-30 | 14,583 | — | $0 | 0 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | D To issuer deriv | 2024-05-30 | 2024-05-30 | 26,667 | — | $0 | 0 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | D To issuer deriv | 2024-05-30 | 2024-05-30 | 6,667 | — | $0 | 0 | SEC↗ |
| FORSYTH DOUGLAS | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| FORSYTH DOUGLAS | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| FORSYTH DOUGLAS | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| FORSYTH DOUGLAS | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 17,259 | — | $0 | 0 | SEC↗ |
| Kayyem Jon Faiz | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| Kayyem Jon Faiz | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| Kayyem Jon Faiz | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 17,259 | — | $0 | 0 | SEC↗ |
| Kayyem Jon Faiz | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| Lappe Mark | Chief Executive Officer | D To issuer deriv | 2024-05-30 | 2024-05-30 | 100,000 | — | $0 | 0 | SEC↗ |
| Lappe Mark | Chief Executive Officer | D To issuer deriv | 2024-05-30 | 2024-05-30 | 145,000 | — | $0 | 0 | SEC↗ |
| MANHARD KIMBERLY | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 3,500 | — | $0 | 0 | SEC↗ |
| MANHARD KIMBERLY | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 17,259 | — | $0 | 0 | SEC↗ |
| MANHARD KIMBERLY | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| MANHARD KIMBERLY | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| MANHARD KIMBERLY | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| Vuori Kristiina MD | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| Vuori Kristiina MD | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 30,000 | — | $0 | 0 | SEC↗ |
| Vuori Kristiina MD | Director | D To issuer deriv | 2024-05-30 | 2024-05-30 | 15,000 | — | $0 | 0 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | J Other deriv | 2024-05-30 | 2024-06-03 | 1,038,765 | $30.00 | $31.16M | 0 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | D To issuer | 2024-05-30 | 2024-05-30 | 1,735,553 | $30.00 | $52.07M | 0 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | D To issuer | 2024-05-30 | 2024-05-30 | 160,000 | $30.00 | $4.80M | 0 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | D To issuer | 2024-05-30 | 2024-05-30 | 160,000 | $30.00 | $4.80M | 0 | SEC↗ |
| FORSYTH DOUGLAS | Director | D To issuer | 2024-05-30 | 2024-05-30 | 598,257 | $30.00 | $17.95M | 0 | SEC↗ |
| Kayyem Jon Faiz | Director | D To issuer | 2024-05-30 | 2024-05-30 | 3,224,301 | $30.00 | $96.73M | 0 | SEC↗ |
| Kayyem Jon Faiz | Director | D To issuer | 2024-05-30 | 2024-05-30 | 25,000 | $30.00 | $750.0K | 0 | SEC↗ |
| Kayyem Jon Faiz | Director | D To issuer | 2024-05-30 | 2024-05-30 | 25,000 | $30.00 | $750.0K | 0 | SEC↗ |
| Lappe Mark | Chief Executive Officer | D To issuer | 2024-05-30 | 2024-05-30 | 2,486,192 | $30.00 | $74.59M | 0 | SEC↗ |
| Lappe Mark | Chief Executive Officer | D To issuer | 2024-05-30 | 2024-05-30 | 59,462 | $30.00 | $1.78M | 0 | SEC↗ |
| Lappe Mark | Chief Executive Officer | D To issuer | 2024-05-30 | 2024-05-30 | 500,000 | $30.00 | $15.00M | 0 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | J Other | 2024-05-30 | 2024-06-03 | 511,627 | $30.00 | $15.35M | 0 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | J Other | 2024-05-30 | 2024-06-03 | 333,333 | $30.00 | $10.00M | 0 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | J Other | 2024-05-30 | 2024-06-03 | 6,305,866 | $30.00 | $189.18M | 0 | SEC↗ |
| Inhibrx, Inc. | 10% Owner | J Other | 2024-05-29 | 2024-05-31 | 13,316,140 | — | $0 | 1,157,926 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2024-05-28 | 2024-05-30 | 300,000 | $34.30 | $10.29M | 1,735,553 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | M Exercise deriv | 2024-05-22 | 2024-05-24 | 2,500 | $34.12 | $85.3K | 26,667 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | M Exercise deriv | 2024-05-22 | 2024-05-24 | 2,510 | $34.12 | $85.6K | 6,667 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-05-06 | 2024-05-08 | 2,087 | $34.24 | $71.5K | 0 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-05-06 | 2024-05-08 | 17,624 | $34.24 | $603.4K | 0 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-26 | 2024-03-28 | 416 | $35.40 | $14.7K | 9,167 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-26 | 2024-03-28 | 396 | $35.40 | $14.0K | 17,624 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-26 | 2024-03-28 | 1,459 | $35.40 | $51.6K | 14,583 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-26 | 2024-03-28 | 625 | $35.40 | $22.1K | 21,250 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-22 | 2024-03-22 | 110 | $35.00 | $3.9K | 18,020 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-21 | 2024-03-22 | 3,113 | $35.09 | $109.2K | 18,130 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-20 | 2024-03-22 | 16,777 | $35.02 | $587.5K | 21,243 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 32,431 | $35.43 | $1.15M | 2,087 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 1,898 | $35.33 | $67.1K | 9,177 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | M Exercise deriv | 2024-03-12 | 2024-03-12 | 19,898 | $35.25 | $701.4K | 11,075 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | M Exercise deriv | 2024-03-12 | 2024-03-12 | 4,152 | $35.25 | $146.4K | 29,167 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | M Exercise deriv | 2024-03-11 | 2024-03-12 | 6,877 | $35.30 | $242.8K | 30,973 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | M Exercise deriv | 2024-03-11 | 2024-03-12 | 6,681 | $35.33 | $236.0K | 33,319 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-08 | 2024-03-12 | 42,523 | $35.75 | $1.52M | 38,020 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | M Exercise deriv | 2024-03-08 | 2024-03-12 | 2,150 | $35.75 | $76.9K | 37,850 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-05 | 2024-03-06 | 10,417 | $35.72 | $372.1K | 9,583 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-04 | 2024-03-06 | 53,958 | $35.40 | $1.91M | 16,042 | SEC↗ |
| Deck Kelly | Chief Financial Officer | M Exercise deriv | 2024-03-04 | 2024-03-06 | 8,125 | $35.60 | $289.3K | 21,875 | SEC↗ |
| Ott David C. | 10% Owner | P Buy deriv | 2023-08-28 | 2023-08-30 | 1,038,765 | $19.35 | $20.10M | 1,038,765 | SEC↗ |
| Ott David C. | 10% Owner | P Buy | 2023-08-28 | 2023-08-30 | 511,627 | $19.35 | $9.90M | 511,627 | SEC↗ |
| Kayyem Jon Faiz | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MANHARD KIMBERLY | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Vuori Kristiina MD | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FORSYTH DOUGLAS | Director | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-03-01 | 2023-03-02 | 400 | $24.71 | $9.9K | 2,035,553 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-03-01 | 2023-03-02 | 39,600 | $24.20 | $958.3K | 2,035,953 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2023-02-28 | 2023-03-01 | 60 | $25.02 | $1.5K | 2,486,192 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-02-02 | 2023-02-02 | 1,130 | $25.89 | $29.3K | 2,075,553 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-02-02 | 2023-02-02 | 10,120 | $25.40 | $257.0K | 2,076,683 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-02-01 | 2023-02-02 | 693 | $25.66 | $17.8K | 2,086,803 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-02-01 | 2023-02-02 | 13,449 | $24.29 | $326.7K | 2,102,104 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-02-01 | 2023-02-02 | 14,608 | $25.08 | $366.4K | 2,087,496 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2023-01-24 | 2023-01-24 | 4,272 | $25.71 | $109.8K | 2,486,315 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2023-01-24 | 2023-01-24 | 63 | $26.11 | $1.6K | 2,486,252 | SEC↗ |
| Kayyem Jon Faiz | Director | S Sale | 2023-01-23 | 2023-01-23 | 9,500 | $25.26 | $240.0K | 3,224,301 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2023-01-23 | 2023-01-24 | 21,665 | $25.36 | $549.4K | 2,490,587 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-01-04 | 2023-01-04 | 3,003 | $23.99 | $72.0K | 2,115,553 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-01-04 | 2023-01-04 | 4,102 | $23.11 | $94.8K | 2,118,556 | SEC↗ |
| Deck Kelly | Chief Financial Officer | A Award deriv | 2023-01-03 | 2023-01-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lappe Mark | Chief Executive Officer | A Award deriv | 2023-01-03 | 2023-01-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | A Award deriv | 2023-01-03 | 2023-01-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-01-03 | 2023-01-04 | 2,084 | $25.09 | $52.3K | 2,122,658 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-01-03 | 2023-01-04 | 8,598 | $24.36 | $209.4K | 2,124,742 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2023-01-03 | 2023-01-04 | 22,213 | $23.41 | $520.0K | 2,133,340 | SEC↗ |
| Kayyem Jon Faiz | Director | S Sale | 2022-12-21 | 2022-12-22 | 1,959 | $27.61 | $54.1K | 3,233,801 | SEC↗ |
| Kayyem Jon Faiz | Director | S Sale | 2022-12-21 | 2022-12-22 | 7,541 | $26.87 | $202.6K | 3,235,760 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-12-19 | 2022-12-20 | 25,246 | $25.53 | $644.5K | 2,513,006 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-12-19 | 2022-12-20 | 754 | $26.29 | $19.8K | 2,512,252 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-12-06 | 2022-12-07 | 1,392 | $28.46 | $39.6K | 2,155,553 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-12-06 | 2022-12-07 | 17,681 | $27.57 | $487.5K | 2,156,945 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-12-06 | 2022-12-07 | 20,927 | $26.83 | $561.5K | 2,174,626 | SEC↗ |
| Kayyem Jon Faiz | Director | S Sale | 2022-11-21 | 2022-11-22 | 2,733 | $29.33 | $80.2K | 3,250,068 | SEC↗ |
| Kayyem Jon Faiz | Director | S Sale | 2022-11-21 | 2022-11-22 | 6,767 | $30.12 | $203.8K | 3,243,301 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-11-17 | 2022-11-18 | 4,333 | $27.45 | $118.9K | 2,548,854 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-11-17 | 2022-11-18 | 1,767 | $28.86 | $51.0K | 2,547,087 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-11-17 | 2022-11-18 | 912 | $30.67 | $28.0K | 2,539,402 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-11-17 | 2022-11-18 | 1,150 | $32.38 | $37.2K | 2,538,252 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-11-17 | 2022-11-18 | 4,106 | $26.57 | $109.1K | 2,553,187 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-11-17 | 2022-11-18 | 6,773 | $30.15 | $204.2K | 2,540,314 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-11-17 | 2022-11-18 | 6,959 | $25.36 | $176.5K | 2,557,293 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-11-01 | 2022-11-02 | 27,651 | $33.34 | $921.9K | 2,207,902 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-11-01 | 2022-11-02 | 12,349 | $33.90 | $418.6K | 2,195,553 | SEC↗ |
| Kayyem Jon Faiz | Director | S Sale | 2022-10-21 | 2022-10-24 | 3,572 | $29.39 | $105.0K | 3,258,729 | SEC↗ |
| Kayyem Jon Faiz | Director | S Sale | 2022-10-21 | 2022-10-24 | 5,928 | $30.58 | $181.3K | 3,252,801 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-10-17 | 2022-10-18 | 2,892 | $30.81 | $89.1K | 2,564,373 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-10-17 | 2022-10-18 | 8,981 | $28.66 | $257.4K | 2,581,271 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-10-17 | 2022-10-18 | 121 | $31.51 | $3.8K | 2,564,252 | SEC↗ |
| Lappe Mark | Chief Executive Officer | S Sale | 2022-10-17 | 2022-10-18 | 14,006 | $29.92 | $419.1K | 2,567,265 | SEC↗ |
| Ott David C. | 10% Owner | P Buy | 2022-10-07 | 2022-10-12 | 1,000,000 | $30.00 | $30.00M | 2,427,307 | SEC↗ |
| Ott David C. | 10% Owner | P Buy | 2022-10-07 | 2022-10-12 | 333,333 | $30.00 | $10.00M | 333,333 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-10-04 | 2022-10-05 | 1,448 | $24.67 | $35.7K | 2,274,105 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-10-04 | 2022-10-05 | 4,262 | $27.76 | $118.3K | 2,252,500 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-10-04 | 2022-10-05 | 6,207 | $26.06 | $161.8K | 2,267,898 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-10-04 | 2022-10-05 | 100 | $30.52 | $3.1K | 2,235,553 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-10-04 | 2022-10-05 | 10,893 | $29.68 | $323.3K | 2,235,653 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-10-04 | 2022-10-05 | 5,954 | $28.97 | $172.5K | 2,246,546 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-10-04 | 2022-10-05 | 11,136 | $26.78 | $298.2K | 2,256,762 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | G Gift | 2022-09-13 | 2022-09-14 | 160,000 | — | $0 | 2,275,553 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | G Gift | 2022-09-13 | 2022-09-14 | 80,000 | — | $0 | 160,000 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | G Gift | 2022-09-13 | 2022-09-14 | 80,000 | — | $0 | 160,000 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-09-06 | 2022-09-07 | 2,493 | $15.66 | $39.0K | 2,435,553 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-09-06 | 2022-09-07 | 37,507 | $14.86 | $557.4K | 2,438,046 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2022-08-24 | 2022-08-25 | 11,900 | — | $0 | 3,262,301 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2022-08-05 | 2022-08-08 | 3,400 | — | $0 | 3,274,201 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-08-03 | 2022-08-04 | 15,500 | $18.47 | $286.3K | 2,475,553 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2022-08-02 | 2022-08-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2022-08-02 | 2022-08-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kayyem Jon Faiz | Director | G Gift | 2022-08-02 | 2022-08-02 | 118,500 | — | $0 | 3,277,601 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-08-02 | 2022-08-04 | 24,500 | $17.70 | $433.6K | 2,491,053 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-07-07 | 2022-07-08 | 40,000 | $17.17 | $686.8K | 2,515,553 | SEC↗ |
| MANHARD KIMBERLY | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 15,000 | — | $0 | 50,759 | SEC↗ |
| Vuori Kristiina MD | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 15,000 | — | $0 | 45,000 | SEC↗ |
| Kayyem Jon Faiz | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 15,000 | — | $0 | 47,259 | SEC↗ |
| FORSYTH DOUGLAS | Director | A Award deriv | 2022-05-25 | 2022-05-26 | 15,000 | — | $0 | 47,259 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2022-04-05 | 2022-04-07 | 400 | $25.04 | $10.0K | 2,555,553 | SEC↗ |
| Deck Kelly | Chief Financial Officer | A Award deriv | 2022-01-11 | 2022-01-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Vuori Kristiina MD | Director | A Award deriv | 2021-12-07 | 2021-12-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MANHARD KIMBERLY | Director | A Award deriv | 2021-06-07 | 2021-06-08 | 15,000 | — | $0 | 35,759 | SEC↗ |
| Kayyem Jon Faiz | Director | A Award deriv | 2021-06-07 | 2021-06-08 | 15,000 | — | $0 | 32,259 | SEC↗ |
| FORSYTH DOUGLAS | Director | A Award deriv | 2021-06-07 | 2021-06-08 | 15,000 | — | $0 | 32,259 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2021-03-24 | 2021-03-24 | 17,000 | $19.02 | $323.3K | 2,555,953 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | S Sale | 2021-02-17 | 2021-02-18 | 19,559 | $25.29 | $494.6K | 215,150 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | S Sale | 2021-02-16 | 2021-02-18 | 156,474 | $24.32 | $3.81M | 234,709 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | S Sale | 2021-02-16 | 2021-02-18 | 17,000 | $25.90 | $440.3K | 2,572,953 | SEC↗ |
| Lappe Mark | Chief Executive Officer | A Award deriv | 2021-01-15 | 2021-01-19 | 145,000 | — | $0 | 145,000 | SEC↗ |
| Deck Kelly | Chief Financial Officer | A Award deriv | 2021-01-15 | 2021-01-19 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Wagner Klaus W. | Chief Medical Officer | A Award deriv | 2021-01-15 | 2021-01-19 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | A Award deriv | 2021-01-15 | 2021-01-19 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Lappe Mark | Chief Executive Officer | G Gift | 2020-12-28 | 2021-01-19 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Lappe Mark | Chief Executive Officer | G Gift | 2020-12-28 | 2021-01-19 | 500,000 | — | $0 | 2,590,252 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | G Gift | 2020-12-04 | 2021-01-19 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | G Gift | 2020-12-04 | 2021-01-19 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Eckelman Brendan P. | Chief Scientific Officer | G Gift | 2020-12-04 | 2021-01-19 | 160,000 | — | $0 | 2,589,953 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | P Buy | 2020-08-26 | 2020-08-28 | 100,000 | $18.99 | $1.90M | 1,427,307 | SEC↗ |
| Viking Global Opportunities Il | 10% Owner | P Buy | 2020-08-26 | 2020-08-28 | 80,219 | $18.84 | $1.51M | 1,327,307 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | P Buy | 2020-08-25 | 2020-08-25 | 14,825 | $19.23 | $285.1K | 1,176,609 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | P Buy | 2020-08-25 | 2020-08-25 | 70,479 | $19.39 | $1.37M | 1,247,088 | SEC↗ |
| VIKING GLOBAL INVESTORS LP | 10% Owner | P Buy | 2020-08-24 | 2020-08-25 | 46,161 | $19.43 | $896.9K | 1,161,784 | SEC↗ |
| MANHARD KIMBERLY | Director | A Award deriv | 2020-08-21 | 2020-08-21 | 17,259 | — | $0 | 17,259 | SEC↗ |
| FORSYTH DOUGLAS | Director | C Conversion deriv | 2020-08-21 | 2020-08-21 | 143,266 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | C Conversion deriv | 2020-08-21 | 2020-08-24 | 3,700,634 | — | $0 | 0 | SEC↗ |
| FORSYTH DOUGLAS | Director | C Conversion | 2020-08-21 | 2020-08-21 | 82,422 | — | $0 | 598,257 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | C Conversion | 2020-08-21 | 2020-08-24 | 2,129,003 | — | $0 | 2,129,003 | SEC↗ |